Sofinnova Ventures β Full Portfolio
201 tracked investments Β· page 1 of 2 Β· listed companies and verified rows first
Clinical-stage biopharmaceutical company focused on identifying, developing and commercializing differentiated medicines for cancer patients.
BiotechMedical DevicesNewtown Square, US
Brent Rice(Chief Commercial Officer)Jason Zhang(Director)Cong Xu(Director)Zhengbin (Bing) Yao(Executive Officer, Director)Stuart Lutzker(Director)
Board seatJames HealyΒ· per SEC Form D Β· $145M raise Β· filed Dec 2022
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.
BiotechHealthtechLongevityRichmond, US
Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Eric Morgen(Director)Dov Goldstein(Executive Officer)Jason Coloma(Director)Kristen Fortney(Executive Officer, Director)
Board seatJames HealyΒ· per SEC Form D
Beltsville, US
Board seatDavid KabakoffΒ· per SEC Form D Β· $21.5M raise Β· filed Dec 2025
Seaport Therapeutics develops therapeutics and medicines.
BiotechMental HealthBoston, US
Daphne Zohar(Founder, CEO and Board Member)Michael Chen(Executive Officer)Lana Gladstein(Executive Officer)Antony Loebel(Executive Officer)Eric Green(Executive Officer)
Board seatJames I. HealyΒ· per SEC Form D
South San Francisco, US
Board seatMaha KatabiΒ· per SEC Form D Β· $70.7M raise Β· filed Feb 2021
Natera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions.
BiotechDigital HealthHealthtechMedical Devices<UNKNOWN>
Matthew Rabinowitz(Co-founder & Executive Chairman)
Aclaris develops investigational monoclonal antibodies and small-molecule inhibitors targeting immune pathways for the treatment of atopic, autoimmune, and respiratory diseases.
BiotechHealthtechMedical DevicesWayne, US
Neal Walker(Executive Officer, Director)Joseph Monahan(Executive Officer)Hugh Davis(Executive Officer, Director)James Loerop(Executive Officer)Kevin Balthaser(Executive Officer)Kamil Ali-Jackson(Executive Officer)
aTyr is a clinical-stage biotechnology company developing therapies derived from tRNA synthetase biology to treat fibrosis and inflammation, with its lead candidate efzofitimod in clinical trials for interstitial lung disease.
BiotechHealthtechMedical DevicesSan Diego, US
Amir Nashat(Non-Management Director)Paul Schimmel(Non-Management Director)Akkaraju Srinivas(Non-Management Director)John D. Mendlein(Executive Officer, Director)David Weiner(Executive Officer)Ed Penhoet(Non-Management Director)
Coherus Oncology develops and commercializes immuno-oncology therapies, including the approved LOQTORZI, to treat patients with cancer.
BiotechHealthtechMedical DevicesRedwood City, US
Barbara K Finck, M.D.(Executive Officer)Ali J. Satvat(Director)Mats Wahlstrom(Director)Alan C. Herman(Executive Officer)Dennis M. Lanfear(Executive Officer, Director)Jean-Frederic Viret, Ph.D.(Executive Officer)
Editas Medicine develops gene-editing medicines using CRISPR technology to treat serious genetic diseases.
BiotechMedical Devices
BiotechHamilton
RICHARD S LEVY(Director)STEPHEN R BIGGAR(Director)FELIX J BAKER(Director)THOMAS W BEETHAM(Executive Officer)SANJ K PATEL(Executive Officer, Director)THOMAS R MALLEY(Director)
BiotechLa Jolla, US
MATTHEW W. FOEHR(Director)JOHN L. HIGGINS(Executive Officer, Director)JOHN LAMATTINA(Director)TODD DAVIS(Director)SUNIL PATEL(Director)JOHN KOZARICH(Director)
San Francisco, US
David Goeddel(Director)Mark Goldsmith(Director)Arthur T. Sands(Executive Officer, Director)Timothy Kutzkey(Executive Officer, Director)
Bedford, US
Prothena is a clinical-stage biotechnology company developing investigational therapies for neurodegenerative and rare peripheral amyloid diseases by targeting misfolded proteins.
BiotechDun Laoghaire, Co. Dublin, US
Richard T. Collier(Director)Tran B. Nguyen(Executive Officer)Arthur W. Homan(Executive Officer)Lars G. Eckman, M.D., Ph.D.(Director)Dennis J. Selkoe(Director)Karin L. Walker(Executive Officer)
Rapport is a biopharmaceutical company developing novel therapeutics.
BiotechHealthtechMedical Devices
Abe Ceesay(President)Cheryl GaultDr. Sevigny
Seres Therapeutics is a clinical-stage biotechnology company developing therapies composed of rationally selected live bacterial consortia to treat serious diseases through modulation of the human microbiome.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Matthew Henn(President and Chief Scientific Officer)
Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases.
BiotechDeep TechMedical DevicesCambridge, US
Ed Mathers(Director)Chau Khuong(Director)Bharatt Chowrira(Executive Officer)Ankit Mahadevia(Director)Michael Sheahan(Executive Officer)Peter Barrett(Director)
South San Francisco, US
Nextcure is a clinical-stage biopharmaceutical company developing immunotherapies targeting IO pathways, with a focus on oncology applications.
BiotechBeltsville, US
Timothy Mayer(Executive Officer)Michael Richman(Executive Officer, Director)Elaine V. Jones(Director)Udayan Guha(Executive Officer)Anne Borgman(Director)Steven P. Cobourn(Executive Officer)
BiotechGaithersburg, US
Evan Loh(Director)Gregory L. Merril(Executive Officer, Director, Promoter)Jonathan Leff(Director)Jana Jensen(Director)Raymond L. Martz(Director)Carl R. Merril(Executive Officer, Director)
Board seatJonathan LeffΒ· per SEC Form D Β· $30M raise Β· filed Jun 2023
Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing selective small molecule inhibitors to treat rare genetic and age-related diseases caused by dysregulated cellular metabolism.
BiotechBerkeley, US
Allison J. Hulme(CEO & President)John Kincaid(Chief Scientific Officer)Youssef Bennani(Director)Themasap Khan(Director)Nils Regge(Director)Davis Ryman(Executive Officer)
Board seatLars EkmanΒ· per SEC Form D
Boston, US
Board seatMaha KatabiJonathan LeffΒ· per SEC Form D Β· $75.8M raise Β· filed Aug 2020
Antiva Biosciences develops a topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions, utilizing antiviral prodrug chemistry.
BiotechFemTechHealthtechMedical DevicesRedwood City, US
Gail Maderis(Director)Kristine Ball(Executive Officer, Director)Elaine Chien(Executive Officer)Sarah Walter(Executive Officer)Raju Gadiraju(Executive Officer)Steven James(Director)
Board seatDavid KabakoffΒ· per SEC Form D
Crestwood, US
Board seatMaha KatabiΒ· per SEC Form D Β· $60.1M raise Β· filed Aug 2017
Durham, US
Board seatChris CarpenterJames HealyΒ· per SEC Form D Β· $150M raise Β· filed Apr 2025
Pleasanton, US
Chih-Ping Liu(Executive Officer, Director, Promoter)Edgar G Engleman(Director)
Board seatJames HealyΒ· per SEC Form D
BiotechCleveland, US
NOEL JEE(Director)JOSEPH RICH(Director)ANDREW SUMMERS(Executive Officer)SAMEER ROHATGI(Director)Arnon Chait(Executive Officer, Director)DARA WRIGHT(Director)
Board seatNoel JeeΒ· per SEC Form D Β· $14.4M raise Β· filed Oct 2025
eFFECTOR Therapeutics was a clinical-stage biopharmaceutical company.
BiotechSolana Beach, US
Stephen F. Worland, Ph.D.(Executive Officer, Director)Alana McNulty(Executive Officer)Simeon George(Director)Jonathan Root(Director)Ken Haas(Director)Laurence Lasky(Director)
Board seatMaha KatabiΒ· per SEC Form D Β· $56M raise Β· filed Feb 2016
Boston, US
Board seatNoel JeeΒ· per SEC Form D Β· $112.3M raise Β· filed Oct 2024
BiotechSan Diego, US
Michael J. Kamdar(Director)Daniel D. Burgess(Director)Richard G. Vincent(Executive Officer)Mark W. Surber, Ph.D.(Executive Officer, Director)
Board seatJonathan LeffΒ· per SEC Form D Β· $189.2M raise Β· filed Oct 2023
Stevenage, Hertfordshire
Board seatMaha KatabiΒ· per SEC Form D Β· $148M raise Β· filed Apr 2021
San Francisco, US
Board seatMaha KatabiΒ· per SEC Form D Β· $160.4M raise Β· filed Jun 2024
South San Francisco, US
Board seatMaha KatabiΒ· per SEC Form D Β· $89.1M raise Β· filed Jun 2026
Seattle, US
Robert Shepler(Director)Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)Brian Daniels(Director)Joseph Victor(Executive Officer, Director)Frank Witney(Director)
Board seatDavid KabakoffΒ· per SEC Form D Β· $35.7M raise Β· filed Jul 2023
RayzeBio develops radiopharmaceutical therapies for cancer treatment.
BiotechHealthtechMedical DevicesSan Diego, US
Ben Hickey(President)Abhi Bhat, PhD(Senior Vice President, Research & Development)Deborah Charych(Executive Officer)Jerel Davis(Director)Ken Song(Executive Officer, Director)Bong Koh(Director)
Board seatMaha KatabiΒ· per SEC Form D
Route 92 Medical develops specialized catheter systems and reperfusion devices for neurovascular interventions, addressing limitations in navigating complex vessel anatomy and reaching stroke treatment targets.
BiotechHealthtechMedical DevicesSan Mateo, US
Tony Chou(Executive Officer, Director)Cindy Lynch(Executive Officer)
BoardJack Lasersohn(Director)Tamir Meiri(Director)Jonathan Root(Director)Ariella Golomb(Director)
Board seatNoel JeeΒ· per SEC Form D Β· $50M raise Β· filed Apr 2026
South San Francisco, US
Board seatMaha KatabiΒ· per SEC Form D Β· $125M raise Β· filed Oct 2025
Aerie Pharmaceuticals develops ophthalmic pharmaceutical products including Rocklatan and Rhopressa for glaucoma and ocular hypertension, and AR-15512 for dry eye disease.
BiotechHealthtechMedical Devices
Jade Biosciences is a clinical-stage company developing therapies that target autoimmune diseases.
BiotechHealthtech
AFYX is a biopharmaceutical company focused on reformulation and repurposing of existing pharmaceuticals for conditions including head and neck cancer, labor induction, cluster headaches, and pain and addiction.
BiotechHealthtechMedical DevicesHΓΈrsholm, DK
Dr. Claus J. MΓΈller-San Pedro(CEO)
Aiolos Bio is a biopharma company that discovers, develops, and delivers medicines and vaccines across respiratory, immunology, inflammation, oncology, HIV, and infectious diseases.
BiotechHealthtech
BiotechBrookline, US
Emmanuel Simons(Executive Officer, Director)Ed Mathers(Director)Kush Parmar(Director)
ANI Pharmaceuticals develops pharmaceutical treatments focused on rare diseases.
BiotechHealthtechMedical Devices
Alkeus Pharma develops therapies for retinal diseases, including inherited and neovascular conditions.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Carlos Quezada-Ruiz(Chief Medical Officer)
Anesiva is a biopharmaceutical company developing Nexletol for diet management.
Biotech
Anthera produces makeup and skincare products made in France with natural, non-toxic ingredients that are cruelty-free and vegan.
ConsumerWellness & FitnessFrance, FR
BiotechVancouver
Andrew I. Koven(Executive Officer)Eric L. Trachtenberg(Executive Officer)Scott J. Charles(Executive Officer)Kenneth B. Lee Jr.(Director)Arthur S. Kirsch(Director)Adrian Adams(Executive Officer, Director)
Ascendis Pharma is a biopharmaceutical company developing therapies for hormone-related disorders and rare diseases.
BiotechHealthtechMedical DevicesDenmark, DK
Jan MΓΈller Mikkelsen(Founder, President and Chief Executive Officer)
A biotechnology company developing new therapies for patients with high unmet medical needs.
Biotech
Axonis Therapeutics develops medicines targeting KCC2 to restore inhibition in the brain, with a focus on treating neurological disorders including epilepsy and pain.
BiotechMedical DevicesBoston, US
Shane Hegarty(Executive Officer)Jeffrey Imbaro(Executive Officer)Joanna Stanicka(Executive Officer, Director)
BoardCorey . Goodman(Director)Jonathan Leff(Director)Raymond J. Kelleher(Director)
BiotechNewton Centre, US
Scott Minick(Director)John A. Scarlett(Director)Chaime Orlev(Executive Officer)Todd T. Foley(Director)Vincent Miles(Director)Ansbert K. Gadicke(Director)
City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands.
BiotechMedical DevicesCambridge, US
Mark Keating, MD(Co-founder)Kotaro Nakanishi, PhD(Co-founder)Yukihide Tomari, PhD(Co-founder)Phillip Zamore, PhD(Co-founder)
Received FDA approval for Tracleer to treat pulmonary arterial hypertension.
Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.
AI & Machine LearningBiotech
Pierre Raboisson(Chief Executive Officer Chief Scientific Officer Co-founder)Marie De Vulder(Chief Legal Officer Co-founder)Guy Peeters(Chief Financial Officer Co-founder)John-Paul Gallivan(Head of Development Co-founder)Fabrice Kolb(Head of Immunology Co-founder)Pieter Peeters(Operating & Technology Officer Co-founder)
BiotechBerkeley Heights, US
Andrew Einhorn(Executive Officer)James Loughlin(Director)Isaac Blech(Director)Albert N. Marchio II(Executive Officer)Robert Spiegel(Director)Kurt Conti(Director)
HealthtechPlymouth, US
John K. Bakewell(Director)Brian E. Farley(Director)Shawn T McCormick(Director)David B. Milne(Director)Douglas Rohlen(Director)Stephen R. Paidosh(Executive Officer)
Gilead is a biopharmaceutical company that develops and markets medicines across virology, oncology, and inflammation therapeutic areas.
BiotechHealthtech
BiotechEmeryville, US
Andrew Allen(Executive Officer, Director)Shefali Agarwal(Director)Lawrence Corey(Director)Vassiliki Economides(Executive Officer)Steve Krognes(Director)Matthew Hawryluk(Executive Officer)
HealthtechWaltham, US
John J. Johnson(Director)Joshua Baltzell(Director)Kevin Rakin(Director)David Gill(Director)Adam Gridley(Executive Officer, Director)Jonathan Lieber(Director)
Incardatherapeutics develops drug therapies for treating atrial fibrillation using synergistic combinations of anti-arrhythmic agents, with delivery platforms designed for both hospital and at-home settings.
BiotechDigital HealthMedical DevicesBrisbane, US
Rangachari Narasimhan(Executive Officer, Director)McCarthy Reenie(Director)Grace Colon(Executive Officer, Director)Bischofberger Norbert(Director)Miller Samantha(Executive Officer)
BiotechBoston, US
Axel Bolte(Executive Officer, Director)Edward Mathers(Director)Reinaldo Diaz(Director)Rob Hopfner(Director)Martin Edwards(Director)Joseph Schlessinger(Executive Officer, Director)
Iterum Therapeutics develops anti-infective compounds to treat infections caused by multi-drug resistant pathogens.
BiotechDigital HealthHealthtechMedical DevicesDublin, US
Brenton K. Ahrens(Director)Michael W. Dunne(Executive Officer, Promoter)Ronald M. Hunt(Director)Mark Chin(Director)Corey N. Fishman(Executive Officer, Director, Promoter)Robert Hopfner(Director)
BiotechRadnor, US
Scott Braunstein, MD(Executive Officer, Director)Enrique J. Carrazana, MD(Director)Michael R. Dougherty(Director)Seth H.Z. Fischer(Director)Tim M. Mayleben(Director)Nicole Vitullo(Director)
HealthtechNew Orleans, US
Dale Pfost(Executive Officer, Director, Promoter)Don Marvin(Director)Mark Heiman(Executive Officer)Richard Montgomery(Director)Ross Barrett(Director)John Elstrott(Director, Promoter)
BiotechAustin, US
Developed next-generation depression pharmaceuticals; acquired in 2015 for $560M upfront plus milestones.
BiotechCambridge, US
Richard Gaynor, M.D.(Executive Officer)Cary Pfeffer, M.D.(Director)Robert Kamen(Director)Eric Lander(Director)Robert Ang, M.D.(Executive Officer)Yasir Al-Wakeel(Executive Officer)
BiotechGrand Prairie, US
Steven Lutz(VP Sales)Carolyn Sikes(VP Clinical Affairs)Arlen Ewart(Controller)Russ McMahen(VP Research and Development)Stacie Switzer(Assistant Secretary)Margaret Cabano(VP Operations)
BiotechSan Diego, US
Kathleen D. Scott(Chief Financial Officer, Secretary and Treasurer)Judy Caron(Chief Operating Officer)David F. Hale(Chairman of the Board of Directors, Acting President and CEO)Brian Dorsey(Director)Daniel Becker(Director)Alex Zisson(Director)
QUILLIVANT XR is a prescription medication containing methylphenidate, indicated for ADHD treatment.
Medical DevicesNew Jersey, US
Keenova Therapeutics is a specialty pharmaceutical company developing treatments for rare, stigmatized, or unaddressed conditions across therapeutic areas including immunology, urology, hepatology, ophthalmology, orthopedics, and critical care.
BiotechHealthtechMedical Devices
OnCusp Therapeutics develops oncology therapeutics for cancer treatment, including antibody-drug conjugates and small molecule compounds in clinical and preclinical stages.
BiotechMedical DevicesNew York, US
Dr. Bing Yuan(Co-Founder, Chief Executive Officer)Dr. Eric Slosberg(Co-Founder, Chief Development Officer)Dr. Andy Fu(Co-Founder, Chief Business Officer)
BiotechNew York, US
David Redlick(Director)Michael Ross(Director)Keith Westby(Executive Officer)David Carroll(Executive Officer)Thomas Dyrberg(Director)Glenn Sblendorio(Executive Officer, Director)
BiotechLa Jolla, US
Preston Klassen(Executive Officer)Joseph Hagan(Executive Officer)Eckard Weber(Director)Brian H. Dovey(Director)Louis C Bock(Director)Patrick J Mahaffy(Director)
HealthtechSan Francisco, US
Leon Chen, Ph.D.(Director)Matthew F. Krummel, Ph.D.(Director)Michael Powell(Director)Carol Gallagher(Director)Joshua Resnick, M.D.(Director)Steven P. James(Executive Officer, Director, Promoter)
BiotechSouth San Francisco, US
MARTIN BABLER(Executive Officer, Director)PETER THOMPSON(Director)SRINIVAS AKKARAJU(Director)LEWIS J. SHUSTER(Director)MICHAEL DYBBS(Director)SIMEON GEORGE(Director)
Pharmaceutical company acquired by Biogen
Pfizer is a pharmaceutical company that develops medicines and therapies across multiple disease areas, supported by extensive scientific research and clinical trials.
BiotechHealthtechMedical DevicesNew York, US
Charles Pfizer
BiotechRockville, US
Bob Holmen(Director)Kristian Humer(Director)Christopher Gerry(Executive Officer, Director)Phillip B. Donenberg(Director)Anand Kiran Parikh(Executive Officer, Director)Tom Ricks(Director)
BiotechLa Jolla, US
Gerald T Proehl(Director)Lars Ekman(Director)Allison E. Hulme(Executive Officer, Director)Randall E. Woods(Executive Officer, Director)John E Geltosky(Director)Peter T. Slover(Executive Officer)
Spark Therapeutics, now part of the Roche Group, focuses on delivering therapies to improve patient outcomes and create healthier communities.
BiotechDigital HealthHealthtechMedical Devices
BiotechOmaha, US
Michael A. Luther(Director)Paul Kinnon(Executive Officer, Director)Leon F. Richards(Executive Officer)Robert M. Patzig(Director)Doit L. Koppler, II(Director)John D. Thompson(Director)
RNA therapeutics; NASDAQ TBIO, acquired by Sanofi.
AbbVie is a biopharmaceutical company that discovers and delivers medicines for immune-mediated diseases and other therapeutic areas globally.
BiotechHealthtechMedical Devices
XyloCor Therapeutics develops gene therapies for advanced coronary artery disease and cardiac damage.
BiotechHealthtechMedical Devices
Ronald Crystal(Co-founder)Todd Rosengart(Co-founder)John Tucker(President and Chief Executive Officer)Glenn Batchelder(Director)James Cohen(Director)Albert Gianchetti(Executive Officer, Director)
Y-mAbs develops radioimmunotherapy and antibody-based therapies targeting pediatric and adult cancers, with a heritage in high-risk neuroblastoma and expansion into additional oncology indications.
BiotechDigital HealthHealthtechMedical Devices
Thomas Gad(Founder, Vice Chairman of the Board of Directors, and Chief Business Officer)
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.